Skip to main content
Caplight Logo









AQUANOVA AG

AQUANOVA AG

Private
DarmstadtHealthcare & Life Scienceshttps://aquanova.de

Company Overview

AQUANOVA AG operates in Healthcare & Life Sciences and is based in Darmstadt. It was founded in 1995.

AQUANOVA AG is a biotechnology company that develops and manufactures liquid colloidal formulations for the food, dietary supplement, pharmaceutical, and cosmetics industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AQUANOVA AG Comparables

Compare AQUANOVA AG with similar companies based on industry and business-model similarity.

AQUANOVA AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nucaps Nanotechnology
83%
Sphera Encapsulation
82%
Liposoma B.V.
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AQUANOVA AG Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for AQUANOVA AG. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Frank Behnam

CEO

Executive Team

For institutional investors. Book with your work email.

AQUANOVA AG Investors

Notable investors and investment history

AQUANOVA AG investors
InvestorRounds
RusnanoVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Monthly visitors grew 62% MoM, reaching 4K.

  • Jun 1, 2025

    Monthly visitors grew 43% MoM, reaching 2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

AQUANOVA AG Filings

Explore SEC and related filing metadata, where available.

AQUANOVA AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AQUANOVA AG's valuation, stock price, and market status.

Is AQUANOVA AG a public or private company?

AQUANOVA AG is a private company.

What is the current stock price of AQUANOVA AG?

AQUANOVA AG is a private company, so its shares have no public market price. Caplight tracks AQUANOVA AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AQUANOVA AG worth (valuation)?

Valuation information for AQUANOVA AG is not publicly available.

Can I buy AQUANOVA AG stock?

AQUANOVA AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AQUANOVA AG's last funding round?

Funding round information for AQUANOVA AG is not publicly available.

Who are the main investors in AQUANOVA AG?

Key investors in AQUANOVA AG include Rusnano.

Will AQUANOVA AG IPO soon?

No public IPO plans have been announced for AQUANOVA AG.

How can I track AQUANOVA AG secondary market activity?

Caplight tracks bids, offers, and trades in AQUANOVA AG's shares on secondary markets.

Firmographic Details

HeadquartersDarmstadt
Employee Range16
Year Founded1995
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?